Related Reading Glp 1 For High Blood Pressure Ozempic For High Blood Pressure Sprout Health Glp 1 Review Plexusdx Glp 1S Pricing and availability current as of June 2026
Lixisenatide and cardiovascular outcomes The first trial which evaluated lixisenatide, published in 2016, was the Evaluation of Lixisenatide in Acute Coronary Syndrome trial which included 6068 patients with T2DM who had sustained an acute coronary event within 180 days before randomization
Results showed average weight reductions of 16.0% on 5 mg, 21.4% on 10 mg, and 22.5% on 15 mg over 72 weeks
For patients with post-acne scarring or more significant hyperpigmentation, the series extends toward six sessions, sometimes with acid type adjusted partway through based on how the skin responds
10.1016/j.carbpol.2016.06.039 44 DarekarS.PatilA.BatheS.DokeR
Paul Strauss Center, Strasbourg